Skip to main content
Andre Nel, MD, Allergy & Immunology, Los Angeles, CA

AndreEliasNelMDD.Sc, MMed

Allergy & Immunology Los Angeles, CA

Distinguished Professor, Medicine, UCLA School of Medicine

Dr. Nel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nel's full profile

Already have an account?

  • Office

    200 Medical Plaza
    #365,530,420,120
    Los Angeles, CA 90095
    Phone+1 310-825-6620

Education & Training

  • Medical University of South Carolina College of Medicine
    Medical University of South Carolina College of MedicineFellowship, Allergy and Immunology, 1983 - 1985
  • Stellenbosch University Faculty of Medicine
    Stellenbosch University Faculty of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2027
  • SC State Medical License
    SC State Medical License 1986 - 1987
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Elected Member The American Society for Clinical Investigation, 1993

Publications & Presentations

PubMed

Journal Articles

  • Nano-Enabled Pancreas Cancer Immunotherapy Using Immunogenic Cell Death and Reversing Immunosuppression  
    Andre Nel, MD, Nature

Press Mentions

  • Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and Abbott
    Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
  • UCLA Researchers Use Nanoparticles to Develop Treatment for Allergies
    UCLA Researchers Use Nanoparticles to Develop Treatment for AllergiesFebruary 7th, 2021
  • Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists Say
    Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists SayMay 5th, 2011
  • Join now to see all

Grant Support

  • Project 2: Relating Enm Physicochemical Properties To Mechanism-Based Pulmonary TNational Institute Of Environmental Health Sciences2010–2012
  • Center For Nanobiology And Predictive ToxicologyNational Institute Of Environmental Health Sciences2010–2012
  • Administrative CoreNational Institute Of Environmental Health Sciences2010–2012
  • Nanovalve Platform: Targeted, Controlled, Release Of Anticancer DrugsNational Cancer Institute2010–2012
  • Nano-Biological Interactions And Toxicity Of Engineered Metal Oxide ParticlesNational Institute Of Environmental Health Sciences2008–2012
  • Predictive Toxicological Paradigms To Establish Inhalation Toxicology ModelsNational Institute Of Environmental Health Sciences2009–2010
  • PM Adjuvant Effects, Dendritic Cells And Hierarchical, Oxidative Stress ResponseNational Institute Of Allergy And Infectious Diseases2007–2010
  • Xenobiotics, Oxidative Stress And Allergic InflammationNational Institute Of Allergy And Infectious Diseases2006–2010
  • Administrative, Subject Recruitment And Sample Coordination CoreNational Institute Of Allergy And Infectious Diseases2006–2010
  • Development Of Methods And Models For Nanoparticle Toxicity Screening: ApplicatioNational Institute Of Environmental Health Sciences2006–2008
  • Atherogenic Effects Of Ambient PM In Susceptible AnimalsNational Institute Of Environmental Health Sciences2004–2007
  • PM Adjuvant Effects, Dendritic Cells Oxidative StressNational Institute Of Allergy And Infectious Diseases2006
  • Lipids Rafts In JNK And Nk-Kb Activation By TCR/CD28National Institute On Aging2002–2006
  • Proteomics Of Dep-Induced Oxidative StressNational Institute Of Environmental Health Sciences2002–2006
  • Biological Analysis Of Toxic DEP ChemicalsNational Institute Of Environmental Health Sciences2002–2006
  • Allergy, Immunology &Transplantation Research CommitteeNational Institute Of Allergy And Infectious Diseases2004–2005
  • Core--Diesel Exhaust Collection And FractionationNational Institute Of Allergy And Infectious Diseases2001–2002
  • Airway Oxidant Stress Response To DEP XenobioticsNational Institute Of Allergy And Infectious Diseases2001–2002
  • Mapkinase Cascades And T Cell Decision MakingNational Institute On Aging1998–2001
  • Xenobiotic Effects On Allergic Responses VIA MacrophagesNational Institute Of Allergy And Infectious Diseases1997–2000
  • Cytokine And Growth Factor Pathways In Kaposis SarcomaNational Cancer Institute1994–1998
  • MAPK Cascades And Function Decline Of Aged T CellsNational Institute On Aging1997
  • Signaling Pathways In IGE Production--Effect Of AdjuvantsNational Institute Of Allergy And Infectious Diseases1994–1996
  • PKC And Tyrosine Kinases Synergize In T-Cell ActivationNational Institute Of General Medical Sciences1992–1995
  • Ibd--Biochemical Pathways In Mucosal T Cell ActivationNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • Tyrosine And C-Kinase Activity And PI Turnover In T-CellNational Institute Of General Medical Sciences1988–1990

Professional Memberships